Gresham House Strategic Plcの資本の返還は37.09%です。
株主資本利益率は、株主資本の簿価との関係で事業の収益性の尺度です。これは、会計年度純利益を株主資本合計で除算することによって計算されます。
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Gresham House Strategic plc specializes in PIPE, pre-IPO, growth and acquisition, recovery capital investments. The fund invests in financial services, media, information and communication technology, digital information and technology, healthcare, and life sciences. It prefers to invest in companies based in United Kingdom and Europe and can also co-invest outside Europe with local venture capital firms. The fund also seeks to make follow on investments. It invests in companies with market capitalizations of less than £250 million ($283.87 million) and seeks to acquire stakes between 5% and 25% for cash or share consideration. It seeks to invest between three to five years. The fund invests in smaller public companies as well as private companies. It invests in public companies that are listed on FTSE All-share and AIM All-Share Index; stocks trading greater than 50% below 3 year price high; EV or EBITDA less than 7 times, gearing more than 75%, ROCE greater than 10%, FCF Yield greater than 10%. The fund invests in private companies in P2P opportunities, equity and equity-related instruments, preferred equity, preferred quasi equity positions including convertible and non-convertible debt instruments, and mezzanine preferred instruments. It attracts portfolio in scenarios - excluding cash, portfolio trades on a weighted average EV or EBITDA greater than 5 times; generating in excess of 10% growth in 2017 based on broker forecasts. The fund targets 15% net IRR over the long-term.